Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $7.43 Million - $8.22 Million
47,625 Added 368.56%
60,547 $9.8 Million
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $23,556 - $28,326
-178 Reduced 1.36%
12,922 $2.06 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $1.34 Million - $1.77 Million
13,100 New
13,100 $1.77 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $193B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Marvin & Palmer Associates Inc Portfolio

Follow Marvin & Palmer Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marvin & Palmer Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Marvin & Palmer Associates Inc with notifications on news.